Drug Database
CH
chloroprocaine hydrochloride (AMP 100 / AMP100 / Iheezo)
✓ ApprovedSintetica SA · Small Molecule · Small Molecule
What is chloroprocaine hydrochloride?
chloroprocaine hydrochloride is a small molecule developed by Sintetica SA. It is approved for therapeutic indications via injectable (others) or intraocular injection or topical.
Drug Profile
| Brand Names | AMP 100, AMP100, Iheezo |
| Company | Sintetica SA |
| Drug Class | Small Molecule |
| Route | Injectable (Others), Intraocular Injection, Topical |
| Status | Approved |
Sources: ClinicalTrials.gov, Sintetica SA
Therapeutic Indications
chloroprocaine hydrochloride is developed for 3 unique indications across 2 therapeutic areas.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Nervous system disorders | Anaesthesia | ✓ Approved |
| Nervous system disorders | Sensory loss | ✓ Approved |
| Gastrointestinal disorders | Abdominal pain | ✓ Approved |
Related Research Articles
Unable to load articles right now.